Pharmacogenomics: introduction and use in clinical practice
Pharmacogenomics describes the link between the genetic code and variations in drug response or adverse effects. It is rapidly gaining in both interest and accessibility. The knowledge of the gene-drug pairing for a wide range of medications will allow the clinician to select drugs with the best eff...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sciendo
2020-06-01
|
| Series: | Romanian Journal of Internal Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.2478/rjim-2020-0001 |
| _version_ | 1811290191263956992 |
|---|---|
| author | Saunders Hollie Harris Dana Chirilă Răzvan M. |
| author_facet | Saunders Hollie Harris Dana Chirilă Răzvan M. |
| author_sort | Saunders Hollie |
| collection | DOAJ |
| description | Pharmacogenomics describes the link between the genetic code and variations in drug response or adverse effects. It is rapidly gaining in both interest and accessibility. The knowledge of the gene-drug pairing for a wide range of medications will allow the clinician to select drugs with the best efficacy, appropriate dose and lowest likelihood of serious side effects. |
| first_indexed | 2024-04-13T04:08:37Z |
| format | Article |
| id | doaj.art-2de50a21f86e4f68aadc0741741ee568 |
| institution | Directory Open Access Journal |
| issn | 2501-062X |
| language | English |
| last_indexed | 2024-04-13T04:08:37Z |
| publishDate | 2020-06-01 |
| publisher | Sciendo |
| record_format | Article |
| series | Romanian Journal of Internal Medicine |
| spelling | doaj.art-2de50a21f86e4f68aadc0741741ee5682022-12-22T03:03:10ZengSciendoRomanian Journal of Internal Medicine2501-062X2020-06-01582697410.2478/rjim-2020-0001rjim-2020-0001Pharmacogenomics: introduction and use in clinical practiceSaunders Hollie0Harris Dana1Chirilă Răzvan M.2Mayo Clinic, Department of Internal Medicine,Jacksonville, FloridaMayo Clinic, Department of Internal Medicine,Jacksonville, FloridaMayo Clinic, Department of Internal Medicine,Jacksonville, FloridaPharmacogenomics describes the link between the genetic code and variations in drug response or adverse effects. It is rapidly gaining in both interest and accessibility. The knowledge of the gene-drug pairing for a wide range of medications will allow the clinician to select drugs with the best efficacy, appropriate dose and lowest likelihood of serious side effects.https://doi.org/10.2478/rjim-2020-0001pharmacogenomicsclinical practicecyp450 |
| spellingShingle | Saunders Hollie Harris Dana Chirilă Răzvan M. Pharmacogenomics: introduction and use in clinical practice Romanian Journal of Internal Medicine pharmacogenomics clinical practice cyp450 |
| title | Pharmacogenomics: introduction and use in clinical practice |
| title_full | Pharmacogenomics: introduction and use in clinical practice |
| title_fullStr | Pharmacogenomics: introduction and use in clinical practice |
| title_full_unstemmed | Pharmacogenomics: introduction and use in clinical practice |
| title_short | Pharmacogenomics: introduction and use in clinical practice |
| title_sort | pharmacogenomics introduction and use in clinical practice |
| topic | pharmacogenomics clinical practice cyp450 |
| url | https://doi.org/10.2478/rjim-2020-0001 |
| work_keys_str_mv | AT saundershollie pharmacogenomicsintroductionanduseinclinicalpractice AT harrisdana pharmacogenomicsintroductionanduseinclinicalpractice AT chirilarazvanm pharmacogenomicsintroductionanduseinclinicalpractice |